Eczema and Psoriasis. A Crisis For Confidence And Emotions: The Importance Of Timely And Effective Treatment
Thursday 30 November 18:00 – 19:00
Eczema and Psoriasis are non-contagious inflammatory dry skin conditions. Eczema can affect people from early infancy to old age. The National Eczema Society estimates that the most common form, atopic eczema, affects 1 in 5 children and 1 in 10 adults in the UK. Psoriasis affects around 2 in 100 people in the UK. It can start at any age, but most often develops in adults between 20 and 30 years old and between 50 and 60 years old.
At the next webinar on the 30th November, Dr Nisa Aslam (GP) takes a look at eczema and psoriasis, the impact they have on confidence and emotions plus the importance of timely and effective treatment for both managing the skin conditions and helping with mental wellbeing.
As part of the webinar, Dr Nisa Aslam will review the very latest real-world patient research for those suffering from eczema and psoriasis and the impact such skin challenges can have on self-confidence, self-esteem, behaviour and mood changes to the effect on the quality of life, relationships and work.
The webinar will detail best practice management of treating eczema and psoriasis reviewing:
- The use of topical corticosteroids
- The eczema treatment algorithms and responses
- The psoriasis treatment algorithms and responses
- A closer look at fludroxycortide tape, what it is and how to use it.
Lasting one hour, the webinar will include a question-and-answer session with Dr Nisa Aslam and is sponsored by the Typharm Group.
This webinar is sponsored by the Typharm Group.
Typharm is a life science company founded in 1966, researching and providing medicines, speciality pharmaceuticals and consumer healthcare products to help improve the lives of millions of people in the UK and around the globe. Patient safety and helping healthcare professionals provide the very best care is at the heart of the company’s operating hub.
Fludroxycortide Tape is a Prescription Only Medicine.
Active ingredients: Fludroxycortide 4 micrograms per square centimetre tape. For Prescribing Information and Adverse Events Reporting, please see: https://www.typharm.com/wp-content/uploads/2020/06/PI-Fludroxycortide-Tape-2.pdf
Job Code: 1/FT/16/2311/829 Date of Preparation: November 2023